FindTrial
Sign In

Application of a Prostate MRI Reliable Joint Segmentation System Based on Conformal Prediction in Biopsy Decision-Making

Application of a Prostate MRI Reliable Joint Segmentation System Based on Conformal Prediction in Biopsy Decision-Making

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127252
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Serum PSA test results were available within 30 days before MRI examination; 3.The images included axial T2W and DWI/ADC sequences with acceptable quality; 4.The patient was assessed by MDT as being at risk and required MRI evaluation;

Exclusion criteria

Exclusion criteria: 1.Previous prostate resection or pelvic radiotherapy; 2.Severe metal artifacts or motion artifacts; 3.Severe lack of clinical data;

Design outcomes

Primary

MeasureTime frame
95% confidence upper bound of csPCa miss rate;absolute error of PSAD (quantitative consistency);Adenoid Dice coefficient (segmentation accuracy);—

Secondary

MeasureTime frame
biopsy avoidance rate (release rate);CP coverage deviation;single-case processing time (workload reduction effect);—

Countries

China

Contacts

Public ContactZhenglin Yi

The First Affiliated Hospital of Kunming Medical University

yizhenglin1217@gmail.com+86 871 65324888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026